ISTH 2022 Congress
COVID and Coagulation » COVID and Coagulation, Clinical
Theme Navigation
- ISTH 2022 Congress
- COVID and Coagulation
- COVID and Coagulation, Clinical
- COVID and Coagulation
-
Abstract Number: PO0012
A frequency of anti-PF4/heparin antibodies and LA in patients with COVID-19
-
Abstract Number: PB0051
A Multicenter Cohort Study of COVID-19 Associated Venous Thromboembolism in Admitted Patients Followed Longitudinally 3-Months After Discharge
-
Abstract Number: OC 13.5
A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico study
-
Abstract Number: VPB0141
A near real-time surveillance algorithm to identify in-hospital VITT cases
-
Abstract Number: PB0045
A pilot, open-label, phase II clinical trial of nebulised recombinant tissue-plasminogen activator in patients with COVID-19 acute respiratory distress syndrome: the PACA trial
-
Abstract Number: PB0054
A role for Von Willebrand Factor-ADAMTS13 axis imbalance and abnormal angiogenesis in Long COVID syndrome
-
Abstract Number: OC 33.3
Absence of Hypercoagulability after nCoV-19 Vaccination: an observational longitudinal study
-
Abstract Number: PB0091
ADAMTS13 in the diagnosis of the severity of COVID-19 mortality
-
Abstract Number: VPB0130
Alterations in the coagulation profile and mortality due to covid-19 during the first and second wave in peruvians: A retrospective cohort in a national reference center.
-
Abstract Number: PB0076
Antiphospholipid antibodies in patients with acute ischaemic stroke during the COVID-19 pandemic
-
Abstract Number: PB0042
Antithrombotics and antihistamine use correlated with increased COVID-19 severity. Antithrombotics and antihistamine use correlated with increased COVID-19 severity.
-
Abstract Number: PB0080
Are drug-drug interactions clinically relevant?. Use of edoxaban concomitant to ritonavir in COVID-19 hospitalized patients with atrial fibrillation
-
Abstract Number: PB0099
Arterial and venous thrombosis induced by vaccination with ChAdOx1 nCov-19 (Astrazeneca) against Coronavirus 19 (COVID19)
-
Abstract Number: OC 13.1
Arterial Thromboembolism Risk Assessment Model in Hospitalized COVID-19 Patients
-
Abstract Number: PB0052
Assessing Endothelial Activation and Risk of Bleeding in patients receiving VV-ECMO supportive therapy for COVID-19 using non-standard laboratory assays
-
Abstract Number: VPB0126
Assessing research collaboration networks and social media use among venous thromboembolism researchers during the COVID-19 pandemic
-
Abstract Number: VPB0104
Assessment of COVID -19 associated coagulopathy and multiple hemostatic markers in patients of upper Egypt.
-
Abstract Number: PB0046
Association between thrombin generation and clinical characteristics in COVID-19 patients
- 1
- 2
- 3
- …
- 7
- Next Page »